Top Markets
#1 Black Phoenix Black Phoenix +166.30%
#2 Islamic Coin Islamic Coin +157.87%
#3 Glidr Glidr +85.63%
#4 Acurast Acurast +35.71%
#5 Cryptopia Cryptopia +21.79%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +19.81%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.73%
#9 DOVU DOVU +15.10%
#10 OVERTAKE OVERTAKE +11.32%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Pozycja w akcjach #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Cena akcji
$0.0009
Ostatnia synchronizacja: 2025-05-27
Kapitalizacja rynkowa
$1.15K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Arch Therapeutics, Inc. (ARTH)

Kategoria

Healthcare
Zyski dla Arch Therapeutics, Inc. (ARTH)
Zyski w Jun 2024 TTM: $-12.26M
Według najnowszych raportów finansowych Arch Therapeutics, Inc., obecny zysk firmy wynosi $-12.26M. W roku 2022 firma osiągnęła zysk w wysokości $-5.28M, wzrost w porównaniu do zysku z roku 2021, który wynosił $-6.24M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Arch Therapeutics, Inc. od 2011 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-12.26M 75.61%
2023 $-6.98M 32.35%
2022 $-5.28M -15.46%
2021 $-6.24M 33.02%
2020 $-4.69M 3.16%
2019 $-4.55M -5.53%
2018 $-4.81M -38.19%
2017 $-7.79M 29.98%
2016 $-5.99M 103.30%
2015 $-2.95M -63.80%
2014 $-8.14M 339.25%
2013 $-1.85M 4,963.48%
2012 $-36.61K 626.84%
2011 $-5.04K 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -43,115.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -16,007.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -24,611.12%
BE